Ofuji's papuloerythroderma: efficacy of interferon-alpha
Plantin, P.; Milochau, P.; Leroy, J.P.; Berthou, C.; Sensebe, L.; Abgrall, J.F.; Guillet, G.
Annales de Dermatologie et de Venereologie 119(9): 643-645
1992
ISSN/ISBN: 0151-9638 PMID: 1285589 Document Number: 390677
Document emailed within 1 workday
Related Documents
Parsad, D.; Gautam, R.K.; Kar, H.K.; Jain, R.K.; Bhardwaj, M. 1995: Papuloerythroderma of ofuji Indian Journal of Dermatology Venereology and Leprology 61(5): 299-300Fujii, K.; Kanno, Y.; Konishi, K.; Ohgou, N. 2003: Relapsing coalescent papular dermatosis of elderly patients: a precursor or an abortive lesion of Ofuji papuloerythroderma European Journal of Dermatology: Ejd 13(3): 272-275
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Toma, S.; Ragni, N.; Raffo, P.; Boselli, F.; Gustavino, C.; Rugiati, S.; Formelli, F.; Palumbo, R.; Rosso, R.; De Cecco, L. 1996: Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study Anticancer Research 16(2): 931-936
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Ma, J.-C.; Wang, L.-W.; Li, X.-J.; Liao, Y.-F.; Hu, X.-Y.; Gong, Z.-J. 2007: Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(2): 166-171
Techapaitoon, S. 1999: Efficacy of high dose interferon--alpha treatment of chronic hepatitis B Journal of the Medical Association of Thailand 82(11): 1118-1126
Abdulkadyrov, K.M.; Rukavitsyn, O.A.; Bessmel'tsev, S.S.; Udal'eva, V.I.; Martynkevich, I.S. 1998: The efficacy of treatment with native lymphoblast alpha-interferon (Wellferon) in patients with chronic myeloleukemia Likars'ka Sprava 4: 108-113
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Pokrovskiĭ, V.I.; Zmyzgova, A.V.; Botsvadze, E.S.; Andreĭchin, M.A.; Frolov, V.M.; Murzabaeva, R.T.; Mesniankin, A.P.; Kokareva, L.N.; Malinovskaia, V.V. 1990: An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B Terapevticheskii Arkhiv 62(2): 139-143
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Sanli, H.; Akay, B.N.; Anadolu, R.; Ozcan, M.; Saral, S.; Akyol, A. 2011: The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome Journal of Drugs in Dermatology: Jdd 10(4): 403-408
Frey, B.; Hofmann, V.; Cavalli, F.; Fehr, J.; Kroner, T.; Nesthus, I.; Schwarzmeier, J. 1988: Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy Schweizerische Medizinische Wochenschrift 118(41): 1468-1475
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364